August J. Troendle - Nov 14, 2023 Form 4 Insider Report for Medpace Holdings, Inc. (MEDP)

Role
CEO, Director, 10%+ Owner
Signature
/s/ Stephen P. Ewald, Attorney-in-Fact for August J. Troendle
Stock symbol
MEDP
Transactions as of
Nov 14, 2023
Transactions value $
-$21,217,980
Form type
4
Date filed
11/16/2023, 04:43 PM
Previous filing
Sep 21, 2023
Next filing
Nov 21, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MEDP Common Stock Sale -$7.08M -25K -0.42% $283.11 5.89M Nov 14, 2023 By Medpace Investors, LLC F1, F2, F3
transaction MEDP Common Stock Sale -$9.35M -33K -0.56% $283.42 5.86M Nov 15, 2023 By Medpace Investors, LLC F1, F3, F4
transaction MEDP Common Stock Sale -$4.79M -17K -0.29% $281.61 5.84M Nov 16, 2023 By Medpace Investors, LLC F1, F3, F5
holding MEDP Common Stock 807K Nov 14, 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported on this Form 4 were effected pursuant to a limit order placed by Medpace Investors, LLC ("MPI") during an open window period.
F2 The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $281.20 to $286.67. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.
F3 The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
F4 The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $282.00 to $286.53. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.
F5 The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $280.10 to $284.11. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.